1. Home
  2. CTKB

as of 12-12-2025 3:44pm EST

$4.89
$0.08
-1.61%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Chart Type:
Time Range:
Founded: 1990 Country:
United States
United States
Employees: N/A City: FREMONT
Market Cap: 433.8M IPO Year: 2021
Target Price: $5.88 AVG Volume (30 days): 1.9M
Analyst Decision: Hold Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.11 EPS Growth: N/A
52 Week Low/High: $2.37 - $7.30 Next Earning Date: 11-05-2025
Revenue: $196,828,000 Revenue Growth: -2.18%
Revenue Growth (this year): -0.1% Revenue Growth (next year): 5.62%

AI-Powered CTKB Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 80.69%
80.69%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: